Combination of <scp>PARP</scp> inhibitor and <scp>CDK4</scp>/6 inhibitor modulates <scp>cGAS</scp>/<scp>STING‐</scp>dependent therapy‐induced senescence and provides “one‐two punch” opportunity with <scp>anti‐PD‐L1</scp> therapy in colorectal cancerTao Wang, Yuping Yin|Cancer Science|2023Cited by 38
Two-Year Outcomes and Biomarker Analysis of Locally Advanced Gastric and Gastroesophageal Junction Adenocarcinoma After Neoadjuvant Chemotherapy and Immunotherapy from the Phase II WuhanUHGI001 TrialXiong Sun, Kaixiong Tao, Anshu Li et al.|Annals of Surgical Oncology|2024Cited by 14
MUS81 Inhibition Enhances the Anticancer Efficacy of Talazoparib by Impairing ATR/CHK1 Signaling Pathway in Gastric CancerTao Wang, Yuping Yin|Frontiers in Oncology|2022Cited by 9
Preoperative serum magnesium level as a prognostic and predictive biomarker in locally advanced gastric cancer patients receiving neoadjuvant immunochemotherapyXiaohang Liu, Yuping Yin, Xiong Sun et al.|World Journal of Surgical Oncology|2025Cited by 2
Oxidative Stress Inflammation Score is the Optimal Inflammatory Prognostic Indicator for Patients with Locally Advanced Gastric Cancer Receiving Neoadjuvant Immunochemotherapy: A Multicenter Retrospective Cohort StudyTianhao Li, Yuping Yin, Kaixiong Tao et al.|Annals of Surgical Oncology|2025Cited by 1